Document is current
Any future updates will be listed below
-
Authors
Bojkova, Denisa
Steinhorst, Katja
Bechtel, Marco
Zoeller, Nadja
Doll, Monika
Ott, Melanie
Rothweiler, Florian
Rothenburger, Tamara
Riecken, Kristoffer https://orcid.org/0000-0001-9050-6766
Fehse, Boris https://orcid.org/0000-0001-9780-7211
Kandler, Joshua D.
Olmer, Ruth
Alcober-Boquet, Lucia https://orcid.org/0009-0009-9928-9388
Michaelis, Martin https://orcid.org/0000-0002-5710-5888
Cinatl, Jindrich
Kippenberger, Stefan
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (GRK:2336)
Deutsche Forschungsgemeinschaft (SFB 1648/1 2024 – 512741711)
Deutsche Forschungsgemeinschaft (SFB 1648/1 2024 – 512741711)
Goethe-Corona-Fonds Heinrich und Fritz Riese-Stiftung HMWK
Frankfurter Stiftung für krebskranke Kinder Goethe-Corona-Fonds
- License Information
-
More Information
Article History
Received: 20 November 2025
Revised: 26 January 2026
Accepted: 24 February 2026
First Online: 18 March 2026
Competing interests
: JC, SK, DB, and KS are inventors on patent application WO2022269013A1 submitted by the Johann Wolfgang Goethe University, Frankfurt, Germany that covers the use of G-quartet-forming ODN inhibiting tumor growth and/or viral or bacterial replication and/or exerting anti-inflammatory effects in mammalian cells.
